GlassScriptPhysician profile
Laura A Bealer
NPI 1386645190
$5,811.76
in general payments reported to CMS, 2019-2025
33 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $633 · 2021: $1,278 · 2022: $1,406 · 2023: $869 · 2024: $718 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,144.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $943.17 | 2019-2022 | |
| Glaukos Corporation | $829.21 | 2020-2025 | Ce-Marked Kxla System, Kxl System (Not Refurbished), Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $703.21 | 2019-2025 | Tecnis Iol, Catalys System, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $567.67 | 2020-2024 | Cequa |
| Abbvie INC. | $505.78 | 2022-2025 | Durysta, Ozurdex, Vuity |
| Oyster Point Pharma, INC. | $289.80 | 2022-2024 | Tyrvaya, Ryzumvi |
| Akorn Operating Company LLC | $191.65 | 2021 | |
| New World Medical,INC. | $166.14 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $158.73 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $140.55 | 2022 | |
| Alcon Vision LLC | $131.42 | 2020-2025 | Rocklatan, Simbrinza, Clareon |
| Bausch & Lomb Americas INC. | $115.75 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Rxsight INC | $112.97 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Kala Pharmaceuticals, INC. | $110.27 | 2019-2022 | |
| Amgen INC. | $108.68 | 2024-2025 | Tepezza |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $92.80 | 2024-2025 | Vevye, Triesence |
| Horizon Therapeutics Plc | $89.93 | 2021-2023 | Tepezza |
| Biotissue Holdings INC. | $88.30 | 2021-2025 | |
| Dompe US, INC. | $80.83 | 2021-2025 | Oxervate |
| Thea Pharma INC. | $72.58 | 2022-2023 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $51.24 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $33.04 | 2020 | |
| Ani Pharmaceuticals, INC. | $32.19 | 2025 | Purified Cortrophin Gel |
| Springworks Therapeutics, INC. | $28.70 | 2025 | Gomekli |
| Eyepoint US, INC. | $24.42 | 2019 | |
| Astellas Pharma US INC | $23.23 | 2025 | Izervay |
| Akorn, INC. | $23.06 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $17.80 | 2024 | Humphrey Hfa |
| Ocular Therapeutix, INC. | $17.22 | 2019 | |
| Aerie Pharmaceuticals, INC. | $16.82 | 2020 | |
| Iridex Corporation | $15.63 | 2021 | |
| Omeros Corporation | $14.87 | 2021 | |
| Sight Sciences, INC. | $14.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Bealer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.